Join Goodwin and the J.P. Morgan Life Sciences Commercial Banking Unit for a discussion of pressing issues facing life sciences companies looking to expand their global footprint:
- Tales from the Trenches: Traps for the unwary when planning clinical trials abroad.
- How can drug and device companies anticipate (and avoid) violations of the Foreign Corrupt Practices Act?
- Money Talk: Ensure financing smooths, rather than complicates, your global footprint.
For registration, please click here.